Clinical Trial Update: REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing REGN7508 to acetylsalicylic acid for venous thromboembolism prevention after total knee arthroplasty; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Acetylsalicylic acid (Aspirin)
• REGN7508

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Symptomatic Venous Thromboembolism (VTE) | Phase 3 | Status: RECRUITING